2-[2-(2,4-Diamino-pyrimidin-5-ylmethyl)-phenoxy]-acetamide

ID: ALA136925

PubChem CID: 10492478

Max Phase: Preclinical

Molecular Formula: C13H15N5O2

Molecular Weight: 273.30

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)COc1ccccc1Cc1cnc(N)nc1N

Standard InChI:  InChI=1S/C13H15N5O2/c14-11(19)7-20-10-4-2-1-3-8(10)5-9-6-17-13(16)18-12(9)15/h1-4,6H,5,7H2,(H2,14,19)(H4,15,16,17,18)

Standard InChI Key:  VCZLYBCGKCGTLD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
    4.8417   -4.6667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1292   -4.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4167   -4.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8500   -5.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1292   -5.9167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7042   -4.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9917   -4.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4167   -5.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1583   -3.4500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2750   -4.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2667   -3.4417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1583   -4.2750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1292   -3.4375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5625   -5.9167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5542   -3.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8708   -3.0417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9917   -5.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5625   -4.6875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2750   -5.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5625   -5.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  1  1  0
  5  4  2  0
  6  3  1  0
  7  6  1  0
  8  5  1  0
  9 15  1  0
 10  7  2  0
 11 10  1  0
 12  9  2  0
 13  2  1  0
 14  4  1  0
 15 11  1  0
 16  9  1  0
 17  7  1  0
 18 10  1  0
 19 17  2  0
 20 19  1  0
  8  3  2  0
 20 18  2  0
M  END

Associated Targets(non-human)

DHFR Dihydrofolate reductase (392 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
folA Dihydrofolate reductase (640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 273.30Molecular Weight (Monoisotopic): 273.1226AlogP: 0.10#Rotatable Bonds: 5
Polar Surface Area: 130.14Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.15CX LogP: 0.27CX LogD: 0.09
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.71Np Likeness Score: -0.90

References

1. Selassie CD, Gan WX, Kallander LS, Klein TE..  (1998)  Quantitative structure-activity relationships of 2, 4-diamino-5-(2-X-benzyl)pyrimidines versus bacterial and avian dihydrofolate reductase.,  41  (22): [PMID:9784101] [10.1021/jm970776j]

Source